Peritoneal carcinomatosis from colorectal cancer: Not a lost cause. Background: Y-90 radioembolization has shown promise in the treatment of unresectable metastatic colorectal cancer (mCRC) and ...

March 19, 2010 (Tampa, Florida) — An interventional radiology treatment using intra-arterial yttrium-90 (Y-90) microspheres (TheraSphere, MDS Nordion) shows promise in prolonging life for ...

Two cohorts of patients were created utilizing International Classification of Disease-10 (ICD-10) codes. All patients were required to have colon cancer (C18), liver metastases (C78.7), and ...

Yttrium-90 (Y90) radioembolization is an alternative treatment for liver cancer that can't be cured with surgery or a liver transplant. Learn more.

MARTINSBURG, WV — WVU Medicine Berkeley Medical Center is now offering a new treatment for liver cancer, according to a community announcement. Y-90 radioembolization is a minimally invasive ...

China has potentially revolutionized cancer therapy by producing Yttrium-90, a powerful beta-emitting isotope used to target liver tumors, using a commercial heavy-water reactor at the Qinshan ...

China has successfully mastered the technology to produce Yttrium-90 (Y-90) from commercial nuclear reactors, making large-scale production possible and paving the way for new breakthroughs in the ...

Nicosia, Cyprus, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that one of the acquisition companies of the previously-announced Biocogency ...

HistoSonics, the developer of the Edison Histotripsy System, announced today 12-month follow-up clinical data from its prospective #HOPE4LIVER trials, design ...